Abstract
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
N C Trippodo, B C Panchal and M Fox
Journal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 619-627;